Sio Gene Therapies Inc.
SIOX · NASDAQ
3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | |
|---|---|---|---|---|
| Market Cap | $49,052 | $136,193 | $60,543 | $162,295 |
| - Cash | $63,729 | $118,986 | $80,752 | $106,999 |
| + Debt | $2,516 | $1,243 | $16,391 | $44,176 |
| Enterprise Value | -$12,161 | $18,450 | -$3,818 | $99,472 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$70,935 | -$29,372 | $0 | -$118,952 |
| % Margin | – | – | – | – |
| Net Income | -$71,887 | -$32,425 | -$72,628 | -$129,065 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.98 | -0.62 | -2.93 | -8.02 |
| % Growth | -58.1% | 78.8% | 63.5% | – |
| Operating Cash Flow | -$60,346 | -$46,589 | -$67,473 | -$134,207 |
| Capital Expenditures | -$695 | -$398 | -$255 | -$202 |
| Free Cash Flow | -$61,041 | -$46,987 | -$67,728 | -$134,409 |